Search | Council For Citizens Against Government Waste

Search

State Action

CCAGW Urges Alaska House Labor and Commerce Committee to Oppose HB 159

HB 159 will fail to achieve its objective to protect consumer privacy.

May 12, 2021
State Action

CCAGW Asks Minnesota Senate Leadership to Urge Conference Committee Members to Strike Out HF 801 Language from SF 972

CCAGW asks Minnesota Senate Leadership to Urge Conference Committee Members to remove Prescription Drug Affordability Act language in the Omnibus Commerce Policy and Finance bill. 

May 3, 2021
State Action

CCAGW Urges Minnesota Conference Committee Members to Strike Out HF 801 Language from SF 972

CCAGW urges Conference Committee Members to remove language from the Prescription Drug Affordability Act in the Omnibus Commerce Policy and Finance bill. 

May 3, 2021
State Action

CCAGW Urges the Oregon Joint Ways and Means Committee to Oppose SB 844

CCAGW urges the Oregon Joint Ways and Means Committee to oppose price control legislation. 

April 26, 2021
State Action

CCAGW Urges North Dakota Governor Doug Burgum to Veto HB 1032

CCAGW urges North Dakota Governor Doug Burgum to veto drug transparency legislation, which will not lower drug costs. 

April 23, 2021
State Action

CCAGW Urges Arkansas Senate Insurance and Commerce Committee to Oppose HB 1881

CCAGW urges the Arkansas Senate Insurance and Commerce Committee to oppose a bill that would establish the 340B Drug Pricing Discrimination Act. 

April 22, 2021
State Action

CCAGW Urges Arkansas House of Representatives to Oppose HB 1881

CCAGW urges the Arkansas House to oppose a bill that would establish the 340B Drug Pricing Discrimination Act. 

April 19, 2021
State Action

CCAGW Urges Arkansas Senate Public Health, Welfare, and Labor Committee to Oppose HB 1709

CCAGW Urges Arkansas Senate Public Health, Welfare, and Labor Committee to oppose drug price contol legislation. 

April 19, 2021
State Action

CCAGW Urges Oklahoma Senate to Oppose HB 1602

HB 1602 will fail to achieve its objective to protect consumer privacy.

April 12, 2021
State Action

CCAGW Urges Maine Joint Committee on Health Coverage Insurance, and Financial Services to Oppose LD 675

LD 675 will not lower drug prices and could deny Maine citizens access to important medicines. 

April 12, 2021
State Action

CCAGW Urges Washington House of Representatives to Oppose SB 5062

SB 5062 will fail to achieve its objective to protect consumer privacy.

April 9, 2021
State Action

CCAGW Urges North Dakota Senate to Oppose HB 1032

CCAGW urges the North Dakota Senate to oppose drug transparency legislation, which will not lower drug costs. 

April 9, 2021

Pages